In COVID-19 clinical update #52, Daniel Griffin reviews differences in attack rates between children and adults, J&J vaccine phase III data, G6PD deficiency and vaccines, NIH halts convalescent plasma trial, dexamethasone in hospitalized patients, data on tocilizumab, and long COVID in children.

Hosts: Daniel Griffin and Vincent Racaniello

Subscribe (free): iTunes, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode * SARS-CoV-2 attack rates in children and adults (Clin Inf Dis) * Documents for J&J COVID-19 vaccine review (FDA) * Convalescent plasma and clinical outcomes (JAMA) * NIH halts convalescent plasma trial (NIH) * Dexamethasone in hospitalized COVID-19 patients (NEJM) * Tocilizumab in hospitalized COVID-19 patients (NEJM) * Update on long COVID prevalence (UK ONS) * Letters read on TWiV 727 * Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to daniel@microbe.tv